Microbubbles/Ultrasound Contrast Agents Market Will Reach USD 1,584.5 Million by 2024: Meticulous Research®

Microbubbles/Ultrasound Contrast Agents Market by Therapeutic Area (Cardiovascular Diseases, Renal and Associated Diseases, and others), by Application (Molecular Imaging, Gene Therapy, Drug Delivery, and Stem Cells Delivery) - Global Forecasts to 2024

Microbubbles/ultrasound contrast agents market has shown strong growth pattern in recent year’s majorly due to technological advancements, benefits of ultrasound technologies over other technologies, favourable reimbursement policies for contrast-enhanced procedures in the U.S., increase in demand for diagnostics & image guided procedures, and growing aging population and subsequent rise in the prevalence of chronic diseases. Moreover, rising microbubble related research provides an opportunity in the development of new technologies due to increasing prevalence of chronic diseases with growing aging population and need for drug discovery and development.

Meticulous Research® in its latest publication on microbubbles/ultrasound contrast agents market states that the global microbubbles/ultrasound contrast agents’ market will increase at a CAGR of 25.2% from 2018 to 2024 to reach USD 1,584.5 million by 2024. Wherein, geographically, North America commanded the largest share in this market followed by Europe. The major share of North America is mainly attributed to the rising aging population, increasing number of chronic diseases, well-established healthcare system with wide spread of suppliers & distributors, higher adoption of innovative technologies, rising technological advancements in healthcare, and higher healthcare spending in the region, especially in the U.S.

Browse in-depth Report on: https://www.meticulousresearch.com/product/microbubbles-ultrasound-contrast-agents-market-2024/

The report provides meticulous analysis of global microbubbles/ultrasound contrast agents market by segmenting it on the basis of therapeutic/disease area (cardiovascular diseases, renal and associated diseases, and others), and application (molecular imaging, gene therapy, drug delivery, and stem cells delivery). Wherein, among therapeutic area, cardiovascular diseases segment commanded the largest share in this market majorly due to increasing prevalence of chronic cardiovascular diseases, rising mortality rate due to stroke and heart attack, and growing need for well diagnosed technology.
The key players analyzed in the global microbubbles/ultrasound contrast agents’ market are Lantheus Holdings, Inc. (U.S.), Bracco (Italy), GE Healthcare (U.S.), Daiichi Sankyo Company, Limited (Japan), and nanoPET Pharma GmbH (Germany).

Free Download Your Sample Report Now!
https://www.meticulousresearch.com/download-sample-report/cp_id=3732

Key Topics Covered in This Report:
1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Advancement in Ultrasound Technologies
4.2.1.1.1. Evolution of Microbubbles
4.2.1.1.2. Miniaturization of Ultrasound Devices
4.2.1.1.2.1. Wearable Ultrasound Pain therapy Device
4.2.1.1.2.2. Flow Focusing Microfluidic Devices (FFMDs)
4.2.1.1.2.3. Handheld Ultrasound Scanners
4.2.1.1.2.4. Phone-Based Ultrasound Systems
4.2.1.2. Benefits over Alternative Technologies
4.2.1.3. Favorable Reimbursement Policies for Ultrasound Contrast Enhanced
Procedures in the U.S.
4.2.1.4. Increase in Demand for Diagnostics & Image Guided Procedures influencing
the Sales of Microbubbles
4.2.1.5. Growing Aging Population and Subsequent Rise in the Prevalence of
Chronic Diseases
4.2.2. Restraints
4.2.2.1. Complexity involved in Conducting Contrast Enhanced
Ultrasound (CEUS) Procedures
4.2.3. Opportunities
4.2.3.1. Rising Microbubbles/ Ultrasound Contrast Agents Related Research
4.2.4. Trends
4.2.4.1. Expansion- A Key Growth Strategy Adopted by Market Players

5. Microbubbles/Ultrasound Contrast Agents Market, by Therapeutic Area
5.1. Introduction
5.2. Cardiovascular Diseases
5.2.1. Drivers
5.2.1.1. High incidence of Stroke Worldwide
5.2.1.2. Improvisation in therapies to Boost the Application in Sonothrombolysis
5.2.2. Sonothrombolysis: Future Potential
5.2.2.1. Prospects: Targeted Microbubbles
5.2.2.2. Prospects: Gene Delivery
5.3. Renal and Associated Diseases
5.3.1. Ultrasound Applications in Kidney
5.3.1.1. Diagnosis between Solid Renal Masses and Pseudo-Tumors
5.3.1.2. Differentiation between Cystic and Solid Lesions of the Kidneys
5.3.1.3. Characterization of Complex Cystic Renal Masses
5.3.1.4. Renal infections
5.3.1.5. Renal Trauma
5.3.1.6. Renal Artery Stenosis
5.3.1.7. Assessment of Percutaneous Ablation therapy
5.3.1.8. Kidney Transplantation
5.3.1.9. Kidney Fibrosis
5.3.2. Drivers
5.3.2.1. Regulatory Changes and Government Support to Boost Clinical Research Related to
Kidney
5.3.3. Restraints
5.3.3.1. Retention of Microbubbles
5.4. Other Diseases

6. Microbubbles/Ultrasound Contrast Agents Market, by Application
6.1. Introduction
6.2. Molecular Imaging
6.2.1. Applications
6.2.2. Trends
6.2.2.1. Development of Novel Microbubbles to Improve Target Binding
6.2.2.2. Development of Novel Microbubbles to Suit the Modalities Used in Imaging
6.2.3. Challenges
6.2.3.1. Currently Ultrasound Molecular Imaging Is Still in Its infancy and Some Challenges Exist
6.3. Gene therapy
6.3.1. Drivers
6.3.2. Methods of Gene therapy
6.4. Drug Delivery
6.4.1. Drivers
6.4.1.1. Growing Number of Researchers in the Field of Drug Delivery Using Microbubbles
6.4.1.2. Rising incidence & Mortality of Cancer & Cardiac Disease to Create Need for Better Drug therapies
6.4.1.3. Growing Researches involving Targeted Drug Delivery Using Microbubbles
6.5. Stem Cell Delivery
6.5.1. Growing Researches

7. Microbubbles/Ultrasound Contrast Agents Market, by Geography
7.1. Introduction
7.2. North America
7.3. Europe
7.4. Asia-Pacific
7.5. Rest of the World

8. Competitive Landscape
8.1. Introduction
8.2. Approvals
8.3. Partnerships, Agreements, and Collaborations
8.4. Expansions & Others

9. Company Profiles(Business overview, Financial overview, Product Portfolio, Strategic Developments)
9.1. Lantheus Holdings, Inc.
9.2. Bracco
9.3. GE Healthcare
9.4. Daiichi Sankyo Company, Limited
9.5. nanoPET Pharma GmbH

10. Appendix
10.1. Questionnaire
10.2. Available Customization

Free Download Your Sample Report Now!
https://www.meticulousresearch.com/download-sample-report/cp_id=3732

Contact Info:
Name: Khushal
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Address: Pune, India
Phone: +91 744-7780008
Website: https://www.meticulousresearch.com/product/microbubbles-ultrasound-contrast-agents-market-2024/

Release ID: 88890188